| Product Code: ETC6738140 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Blood Clotting Factor Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Blood Clotting Factor Market Revenues & Volume, 2021 & 2031F |
3.3 China Blood Clotting Factor Market - Industry Life Cycle |
3.4 China Blood Clotting Factor Market - Porter's Five Forces |
3.5 China Blood Clotting Factor Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 China Blood Clotting Factor Market Revenues & Volume Share, By Test, 2021 & 2031F |
3.7 China Blood Clotting Factor Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 China Blood Clotting Factor Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 China Blood Clotting Factor Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 China Blood Clotting Factor Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of hemophilia and other bleeding disorders in China |
4.2.2 Growing awareness about the importance of early diagnosis and treatment of bleeding disorders |
4.2.3 Technological advancements in blood clotting factor products and therapies |
4.3 Market Restraints |
4.3.1 High cost associated with blood clotting factor products, limiting access for some patients |
4.3.2 Stringent regulatory requirements for approval of blood clotting factor products in China |
4.3.3 Limited availability of skilled healthcare professionals specializing in managing bleeding disorders |
5 China Blood Clotting Factor Market Trends |
6 China Blood Clotting Factor Market, By Types |
6.1 China Blood Clotting Factor Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 China Blood Clotting Factor Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 China Blood Clotting Factor Market Revenues & Volume, By Clinical Laboratory Analysers, 2021- 2031F |
6.1.4 China Blood Clotting Factor Market Revenues & Volume, By Point-Of-Care Testing Analysers, 2021- 2031F |
6.2 China Blood Clotting Factor Market, By Test |
6.2.1 Overview and Analysis |
6.2.2 China Blood Clotting Factor Market Revenues & Volume, By Prothrombin Time Testing, 2021- 2031F |
6.2.3 China Blood Clotting Factor Market Revenues & Volume, By Fibrinogen Testing, 2021- 2031F |
6.2.4 China Blood Clotting Factor Market Revenues & Volume, By Activated Partial Thromboplastin Time Testing, 2021- 2031F |
6.2.5 China Blood Clotting Factor Market Revenues & Volume, By Activated Clotting Time Testing, 2021- 2031F |
6.2.6 China Blood Clotting Factor Market Revenues & Volume, By D-Dimer Testing, 2021- 2031F |
6.2.7 China Blood Clotting Factor Market Revenues & Volume, By Platelet Function Tests, 2021- 2031F |
6.2.8 China Blood Clotting Factor Market Revenues & Volume, By Heparin and Protamine Dose Response Tests for ACT, 2021- 2031F |
6.2.9 China Blood Clotting Factor Market Revenues & Volume, By Heparin and Protamine Dose Response Tests for ACT, 2021- 2031F |
6.3 China Blood Clotting Factor Market, By Technology |
6.3.1 Overview and Analysis |
6.3.2 China Blood Clotting Factor Market Revenues & Volume, By Mechanical Technology, 2021- 2031F |
6.3.3 China Blood Clotting Factor Market Revenues & Volume, By Optical Technology, 2021- 2031F |
6.3.4 China Blood Clotting Factor Market Revenues & Volume, By Electrochemical Technology, 2021- 2031F |
6.3.5 China Blood Clotting Factor Market Revenues & Volume, By Others, 2021- 2031F |
6.4 China Blood Clotting Factor Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 China Blood Clotting Factor Market Revenues & Volume, By Bleeding Disorders, 2021- 2031F |
6.4.3 China Blood Clotting Factor Market Revenues & Volume, By Acquired Bleeding Disorders, 2021- 2031F |
6.4.4 China Blood Clotting Factor Market Revenues & Volume, By Von Willebrand Disease, 2021- 2031F |
6.4.5 China Blood Clotting Factor Market Revenues & Volume, By Haemophilia, 2021- 2031F |
6.5 China Blood Clotting Factor Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 China Blood Clotting Factor Market Revenues & Volume, By Academic Institutions, 2021- 2031F |
6.5.3 China Blood Clotting Factor Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.4 China Blood Clotting Factor Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
6.5.5 China Blood Clotting Factor Market Revenues & Volume, By Others, 2021- 2031F |
7 China Blood Clotting Factor Market Import-Export Trade Statistics |
7.1 China Blood Clotting Factor Market Export to Major Countries |
7.2 China Blood Clotting Factor Market Imports from Major Countries |
8 China Blood Clotting Factor Market Key Performance Indicators |
8.1 Average time to diagnosis of bleeding disorders in China |
8.2 Adoption rate of new blood clotting factor therapies in the Chinese market |
8.3 Number of hemophilia treatment centers and specialized healthcare professionals in China |
9 China Blood Clotting Factor Market - Opportunity Assessment |
9.1 China Blood Clotting Factor Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 China Blood Clotting Factor Market Opportunity Assessment, By Test, 2021 & 2031F |
9.3 China Blood Clotting Factor Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.4 China Blood Clotting Factor Market Opportunity Assessment, By Application, 2021 & 2031F |
9.5 China Blood Clotting Factor Market Opportunity Assessment, By End User, 2021 & 2031F |
10 China Blood Clotting Factor Market - Competitive Landscape |
10.1 China Blood Clotting Factor Market Revenue Share, By Companies, 2024 |
10.2 China Blood Clotting Factor Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here